Prepared by: Best Practices in MS Therapies Roundtable Group Best Practices Group Program Chair: Fred D. Lublin, MD, FAAN, FANA
TOPICS
- Evolving Diagnostic Concepts in Multiple Sclerosis
Erin S. Beck, MD, PhD - Evolving Concepts in Multiple Sclerosis Clinical Course and Prognosis
Fred D. Lublin, MD, FAAN, FANA - Update on Disease-Modifying Therapy for Relapsing and Progressive Forms of MS
Corey C. Ford, MD, PhD - Biomarkers of Disease Risk, Severity, and DMT Efficacy
Ahmed Obeidat, MD, PhD - Updates on Diagnosis and Management of Pediatric-Onset MS
E. Ann Yeh, MA, MD, FRCPC, Dip ABPN - Vaccination Recommendations for People With MS: Impact on MS Risk, Therapy,
and Vaccine Adverse Effects
Anne Cross, MD - Management of MS in an Aging Population
Jennifer Graves, MD, PhD - Diagnosis and Management of Non-MS Demyelinating Conditions: NMOSD and MOGAD
Robert P. Lisak, MD
Developed independently by the CMSC with support from Novartis Pharmaceuticals Corporation
